 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval& C" x% \ ]% D/ s" ^8 |
/ t: x! I; R i( FEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
3 G$ ?! t# B' V1 g* B5 e, C S2 K5 q' s4 |4 Y5 g4 f7 W; W
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007) d8 s1 s( u, G1 \, W" a6 v$ {5 k
7 S' M+ t: C/ I 5 M" j6 O7 H3 Y) {
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.% x( ?$ W: y& h
7 m/ n4 z" `- z# K4 JThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
7 y7 O, e9 a% K9 x3 v# u& C, i1 |, J1 i5 f+ E8 x% s$ q
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.- d9 {* G9 A1 _2 Y# K
+ R. B# Y" x. N8 H6 W1 i$ c( lIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday., I- R2 b1 s; a, b5 L- i8 ?( M
1 O; Z. E9 P. ^% O4 l: @: NIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.4 [' k) n( h- X' N4 S6 y5 u7 l
1 t9 T+ @0 Z, L$ P
"As a scientist, it's one of the highlights of my CAREER," Shan said.
/ v. W& p, T; {: N
/ W# ~7 A0 M, U; c- u"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
+ z! Y G1 f- o, B8 d# e- w5 K
1 B; R1 S8 L; |' N' o. m0 TIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
! d* r& X* {7 g3 o
' l: x" s' ]7 p4 M1 Z4 nGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth. h0 o$ P# P" d' K
! V8 S$ B5 b% w: r4 O3 \, e
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.- c3 h6 I) E2 m9 [
9 \: A- s& h; Q& |6 p+ i
6 Z/ X, r4 k( u B, j. ]
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
# H# U% C! c9 |+ i) @0 P
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
# ]" d9 ]8 s$ X: m7 E2 v
发表于 2015-2-28 19:45
